The retinal tolerance to bevacizumab in co-application with a recombinant tissue plasminogen activator.
Lüke M, Januschowski K, Warga M, Beutel J, Leitritz M, Gelisken F, Grisanti S, Schneider T, Lüke C, Bartz-Schmidt KU, Szurman P; Tuebingen Bevacizumab Study Group.
Lüke M, et al. Among authors: szurman p.
Br J Ophthalmol. 2007 Aug;91(8):1077-82. doi: 10.1136/bjo.2006.111260. Epub 2007 Mar 23.
Br J Ophthalmol. 2007.
PMID: 17383998
Free PMC article.